BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32122381)

  • 21. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
    Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organ preservation following short-course radiotherapy for rectal cancer.
    Nilsson PJ; Ahlberg M; Kordnejad S; Holm T; Martling A
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34686879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.
    Siddiqui MR; Bhoday J; Battersby NJ; Chand M; West NP; Abulafi AM; Tekkis PP; Brown G
    World J Gastroenterol; 2016 Oct; 22(37):8414-8434. PubMed ID: 27729748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
    Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
    Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II-III resectable rectal cancer: 5-Year survival data of a randomized controlled trial.
    Kairevičė L; Latkauskas T; Tamelis A; Petrauskas A; Paužas H; Žvirblis T; Jaruševičius L; Saladžinskas Ž; Pavalkis D; Jančiauskienė R
    Medicina (Kaunas); 2017; 53(3):150-158. PubMed ID: 28690144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
    Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
    Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of long-course oxaliplatin and bolus of fluorouracil based preoperative chemoradiotherapy vs. 5x5Gy radiation plus FOLFOX4 for locally advanced resectable rectal cancer.
    Wang S; Wen F; Zhang P; Wang X; Li Q
    Radiat Oncol; 2019 Jun; 14(1):113. PubMed ID: 31234886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of MRI in Restaging Locally Advanced Rectal Cancer After Preoperative Chemoradiation.
    van den Broek JJ; van der Wolf FS; Lahaye MJ; Heijnen LA; Meischl C; Heitbrink MA; Schreurs WH
    Dis Colon Rectum; 2017 Mar; 60(3):274-283. PubMed ID: 28177989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.
    Hodges N; Battersby N; Rao S; Brown G;
    Ann Surg Oncol; 2023 Aug; 30(8):4729-4735. PubMed ID: 35771366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review.
    Valentini V; Glimelius B; Haustermans K; Marijnen CA; Rödel C; Gambacorta MA; Boelens PG; Aristei C; van de Velde CJ
    Radiother Oncol; 2014 Jan; 110(1):195-8. PubMed ID: 24286634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Good and complete responding locally advanced rectal tumors after chemoradiotherapy: where are the residual positive nodes located on restaging MRI?
    Heijnen LA; Lambregts DM; Lahaye MJ; Martens MH; van Nijnatten TJ; Rao SX; Riedl RG; Buijsen J; Maas M; Beets GL; Beets-Tan RG
    Abdom Radiol (NY); 2016 Jul; 41(7):1245-52. PubMed ID: 26814499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to preoperative short-course radiotherapy in locally advanced rectal cancer: value of f-fluorodeoxyglucose positron emission tomography.
    Siegel R; Dresel S; Koswig S; Gebauer B; Hunerbein M; Schneider W; Schlag PM
    Onkologie; 2008 Apr; 31(4):166-72. PubMed ID: 18418017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution.
    Roy A; Mahasittiwat P; Weiner AA; Hunt SR; Mutch MG; Birnbaum EH; Kodner IJ; Read TE; Fleshman JW; Olsen JR; Myerson RJ; Parikh PJ
    Pract Radiat Oncol; 2017; 7(1):e51-e58. PubMed ID: 27720702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer.
    Kaytan-Saglam E; Balik E; Saglam S; Akgün Z; Ibis K; Keskin M; Dagoglu N; Kapran Y; Gulluoglu M
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1597-1603. PubMed ID: 28374169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?
    van der Sande ME; Beets GL; Hupkens BJ; Breukink SO; Melenhorst J; Bakers FC; Lambregts DM; Grabsch HI; Beets-Tan RG; Maas M
    Eur J Surg Oncol; 2019 Jun; 45(6):1011-1017. PubMed ID: 30528891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
    Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 40. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
    Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
    Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.